Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
This study is currently recruiting participants.
Verified May 2013
by Xian-Janssen Pharmaceutical Ltd.
Study NCT01551290 Information provided by Xian-Janssen Pharmaceutical Ltd.
First Received on March 7, 2012. Last Updated on May 30, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Inflammatory Bowel Diseases
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
Xian-Janssen Pharmaceutical Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers